Latest Breaking News On - Arrowhead pharmaceuticals trading down - Page 1 : vimarsana.com

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Trading Down 6 5% After Earnings Miss

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Trading Down 6 5% After Earnings Miss
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesHongbo luKenneth allen myszkowskiNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals company profileCapital international investorsArrowhead pharmaceuticals incSecurities exchange commissionRoyal bankGoldman sachs group incArrowhead pharmaceuticals trading downArrowhead pharmaceuticalsMorgan stanleyNorges bankAvoro capital advisorsGet free report

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Earnings Results, Misses Estimates By $0 96 EPS

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Earnings Results, Misses Estimates By $0 96 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesHongbo luArrowhead pharmaceuticalsSecurities exchange commissionMorgan stanleyArrowhead pharmaceuticals trading downNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals incEarnings history for arrowhead pharmaceuticalsArrowhead pharmaceuticals company profileInsider transactions at arrowhead pharmaceuticalsRoyal bankGet free reportPharmaceuticals trading downExchange commissionDirector victoria vakiener

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Receives $51 25 Consensus Price Target from Analysts

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Receives $51 25 Consensus Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesArrowhead pharmaceuticalsHedge funds weigh in on arrowhead pharmaceuticalsSecurities exchange commissionMorgan stanleyArrowhead pharmaceuticals trading downNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals company profileWashington trust advisors incAnalyst recommendations for arrowhead pharmaceuticalsRoyal bankFifth third bancorpThird bancorpAdvisors asset management incArrowhead pharmaceuticals incGet free report

Short Interest in Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Decreases By 13 0%

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 7,720,000 shares, a decrease of 13.0% from the January 15th total of 8,870,000 shares. Based on an average daily volume of 1,550,000 shares, […]

United statesChristopher richard anzaloneNews ratings for arrowhead pharmaceuticals dailyInsider activity at arrowhead pharmaceuticalsArrowhead pharmaceuticalsArrowhead pharmaceuticals company profileWashington trust advisors incMorgan stanleyArrowhead pharmaceuticals trading downStar investment management corpArrowhead pharmaceuticals incRoyal bankThird bancorpInstitutional trading of arrowhead pharmaceuticalsFifth third bancorpGet free report

Arrowhead Pharmaceuticals (NASDAQ:ARWR) PT Raised to $34 00

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) had its target price hoisted by analysts at Citigroup from $33.00 to $34.00 in a report released on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the biotechnology company’s stock. Citigroup’s price objective would suggest a potential upside of 8.35% from the stock’s previous close. […]

United statesChristopher richard anzaloneFund management coRoyal bankNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals trading downYousif capital managementAnalyst recommendations for arrowhead pharmaceuticalsAssociates corpSecurities exchange commissionMorgan stanleyArrowhead pharmaceuticalsRussell investments group ltdInsider activity at arrowhead pharmaceuticalsArrowhead pharmaceuticals incInstitutional trading of arrowhead pharmaceuticals